The GLP-1 Boom Is a Tailwind for Clean Eatz Franchisees
One in eight American adults now takes a GLP-1 medication. Drugs like Ozempic, Wegovy, Mounjaro, and Zepbound have moved from niche prescriptions to mainstream use. And they are quietly changing how the country eats. For most restaurant operators, this trend looks like a threat. JPMorgan analysts estimate that GLP-1 drugs could pull between $30 billion […]